Mirja M Wirtz1,2, Susanne Temming3,4, Martin Kocher3, Sabine Kunze3, Robert Semrau3,5. 1. Department of Radiation Oncology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne/Koeln, Germany. mirjawirtz@web.de. 2. Department of Internal Medicine, Geisinger Medical Center, 100 N Academy Ave, 17822, Danville, PA, USA. mirjawirtz@web.de. 3. Department of Radiation Oncology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne/Koeln, Germany. 4. Department of Radiation Oncology, Robert-Janker Klinik, Villenstr. 8, 53129, Bonn, Germany. 5. Strahlentherapie Bonn Rhein-Sieg, Hospitalstr. 45, 53840, Troisdorf, Germany.
Abstract
PURPOSE: The role of postoperative irradiation to contralateral non-involved neck nodes in lateralized carcinoma of the head and neck is not clear. The contralateral neck failure rate in head and neck carcinoma treated postoperatively with ipsilateral neck irradiation only was evaluated. METHODS: Patients with carcinoma of the oral cavity, oropharynx, or hypopharynx without midline extension treated between 1990 and 2016 were analyzed. After tumor resection and neck dissection (ND), radiotherapy was given to the primary tumor site and ipsilateral neck. High-risk patients additionally received concurrent chemotherapy. Freedom from contralateral neck recurrence (FCNR), locoregional control rate (LRC), overall survival (OS), and disease-free survival (DFS) were evaluated. RESULTS: 197 patients (median age 60.7 years, 66.5% males, 52.8% oropharyngeal carcinomas) were analyzed. Complete resection (R0) was achieved in 85.8% of cases. Ipsilateral ND was performed in all patients and contralateral ND in 144 patients (73.1%). Concurrent chemotherapy was given to 59 patients (30.0%). After a median follow-up of 45.5 months, OS and DFS of all patients were 73.6% and 70.9% at 5 years, respectively. A total of 45 patients (22.8%) suffered from a locoregional recurrence, lymph node metastases of the contralateral neck developed in 12 patients (6.1%) only. There was no significant difference in contralateral nodal failure rate with or without performance of contralateral ND. CONCLUSION: Regional failure of the contralateral neck was low after surgery and ipsilateral neck irradiation in head and neck carcinomas without midline extension, supporting evidence that contralateral neck radiotherapy can safely be omitted in selected cases.
PURPOSE: The role of postoperative irradiation to contralateral non-involved neck nodes in lateralized carcinoma of the head and neck is not clear. The contralateral neck failure rate in head and neck carcinoma treated postoperatively with ipsilateral neck irradiation only was evaluated. METHODS:Patients with carcinoma of the oral cavity, oropharynx, or hypopharynx without midline extension treated between 1990 and 2016 were analyzed. After tumor resection and neck dissection (ND), radiotherapy was given to the primary tumor site and ipsilateral neck. High-risk patients additionally received concurrent chemotherapy. Freedom from contralateral neck recurrence (FCNR), locoregional control rate (LRC), overall survival (OS), and disease-free survival (DFS) were evaluated. RESULTS: 197 patients (median age 60.7 years, 66.5% males, 52.8% oropharyngeal carcinomas) were analyzed. Complete resection (R0) was achieved in 85.8% of cases. Ipsilateral ND was performed in all patients and contralateral ND in 144 patients (73.1%). Concurrent chemotherapy was given to 59 patients (30.0%). After a median follow-up of 45.5 months, OS and DFS of all patients were 73.6% and 70.9% at 5 years, respectively. A total of 45 patients (22.8%) suffered from a locoregional recurrence, lymph node metastases of the contralateral neck developed in 12 patients (6.1%) only. There was no significant difference in contralateral nodal failure rate with or without performance of contralateral ND. CONCLUSION: Regional failure of the contralateral neck was low after surgery and ipsilateral neck irradiation in head and neck carcinomas without midline extension, supporting evidence that contralateral neck radiotherapy can safely be omitted in selected cases.
Entities:
Keywords:
Contralateral lymph node metastases; Head and neck cancer; Head and neck squamous cell carcinoma; Oropharyngeal cancer; Unilateral postoperative radiotherapy
Authors: Shlomo A Koyfman; Nofisat Ismaila; Doug Crook; Anil D'Cruz; Cristina P Rodriguez; David J Sher; Damian Silbermins; Erich M Sturgis; Terance T Tsue; Jared Weiss; Sue S Yom; F Christopher Holsinger Journal: J Clin Oncol Date: 2019-02-27 Impact factor: 44.544
Authors: Marije R Vergeer; Patricia A H Doornaert; Anja Jonkman; Johannes H A M Kaanders; Piet L A van den Ende; Martin A de Jong; C Rene Leemans; Ben J Slotman; Johannes A Langendijk Journal: Int J Radiat Oncol Biol Phys Date: 2010-02-25 Impact factor: 7.038
Authors: Harry Quon; Neha Vapiwala; Arlene Forastiere; Erin B Kennedy; David J Adelstein; Holly Boykin; Joseph A Califano; F Chris Holsinger; Brian Nussenbaum; David I Rosenthal; Lillian L Siu; John N Waldron Journal: J Clin Oncol Date: 2017-10-24 Impact factor: 44.544
Authors: Clare Schilling; Sandro J Stoeckli; Stephan K Haerle; Martina A Broglie; Gerhard F Huber; Jens Ahm Sorensen; Vivi Bakholdt; Annelise Krogdahl; Christian von Buchwald; Anders Bilde; Lars R Sebbesen; Edward Odell; Benjamin Gurney; Michael O'Doherty; Remco de Bree; Elisabeth Bloemena; Geke B Flach; Pedro M Villarreal; Manuel Florentino Fresno Forcelledo; Luis Manuel Junquera Gutiérrez; Julio Alvarez Amézaga; Luis Barbier; Joseba Santamaría-Zuazua; Augusto Moreira; Manuel Jacome; Maurizio Giovanni Vigili; Siavash Rahimi; Girolamo Tartaglione; Georges Lawson; Marie-Cecile Nollevaux; Cesare Grandi; Davide Donner; Emma Bragantini; Didier Dequanter; Philippe Lothaire; Tito Poli; Enrico M Silini; Erinco Sesenna; Giles Dolivet; Romina Mastronicola; Agnes Leroux; Isabel Sassoon; Philip Sloan; Mark McGurk Journal: Eur J Cancer Date: 2015-11-18 Impact factor: 9.162
Authors: Hisham Mehanna; Wai-Lup Wong; Christopher C McConkey; Joy K Rahman; Max Robinson; Andrew G J Hartley; Christopher Nutting; Ned Powell; Hoda Al-Booz; Martin Robinson; Elizabeth Junor; Mohammed Rizwanullah; Sandra V von Zeidler; Hulya Wieshmann; Claire Hulme; Alison F Smith; Peter Hall; Janet Dunn Journal: N Engl J Med Date: 2016-03-23 Impact factor: 91.245
Authors: Matthias Balk; Robin Rupp; Konstantinos Mantsopoulos; Matti Sievert; Magdalena Gostian; Moritz Allner; Philipp Grundtner; Markus Eckstein; Heinrich Iro; Markus Hecht; Antoniu-Oreste Gostian Journal: J Clin Med Date: 2022-05-10 Impact factor: 4.964
Authors: Matthias Balk; Robin Rupp; Konstantin Mantsopoulos; Moritz Allner; Philipp Grundtner; S K Mueller; Maximilian Traxdorf; Markus Eckstein; Stefan Speer; Sabine Semrau; Rainer Fietkau; Heinrich Iro; Markus Hecht; Antoniu-Oreste Gostian Journal: BMC Cancer Date: 2021-11-18 Impact factor: 4.430
Authors: D Strüder; S Hellwig; H Rennau; S van Bonn; S P Schraven; R Mlynski; G Hildebrandt; T Schuldt Journal: Eur Arch Otorhinolaryngol Date: 2020-09-01 Impact factor: 2.503